3-(dimethylamino)-1-(4-methylphenyl)-2-phenylprop-2-en-1-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 英文名称: 3-(dimethylamino)-1-(4-methylphenyl)-2-phenylprop-2-en-1-one
• 英文别名: (Z)-3-(dimethylamino)-1-(4-methylphenyl)-2-phenylprop-2-en-1-one
• 化学式: C₁₈H₁₉NO
• 分子量: 265.355
• InChiKey: KWEGAERWNXZJRP-LGMDPLHJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  20
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  3-(dimethylamino)-1-(4-methylphenyl)-2-phenylprop-2-en-1-one 、 氰乙酰胺 在 sodium hydride 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以71%的产率得到6-(4-甲基苯基)-2-氧代-5-苯基-1H-吡啶-3-腈
  参考文献：
  名称：

  Rapid assembly of diverse and potent allosteric Akt inhibitors

  摘要：

  This paper describes the rapid assembly of four different classes of potent Akt inhibitors from a common intermediate. Among them, a pyridopyrimidine series displayed the best intrinsic and cell potency against Akt1 and Akt2. This series also showed a promising pharmacokinetic pro. le and excellent selectivity over other closely related kinases. (C) 2008 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.10.023
• 作为产物：
  描述：

  N,N-二甲基甲酰胺二甲基缩醛 、 4-甲基-2-苯基苯乙酮 以 N,N-二甲基甲酰胺 为溶剂， 以85%的产率得到3-(dimethylamino)-1-(4-methylphenyl)-2-phenylprop-2-en-1-one
  参考文献：
  名称：

  Rapid assembly of diverse and potent allosteric Akt inhibitors

  摘要：

  This paper describes the rapid assembly of four different classes of potent Akt inhibitors from a common intermediate. Among them, a pyridopyrimidine series displayed the best intrinsic and cell potency against Akt1 and Akt2. This series also showed a promising pharmacokinetic pro. le and excellent selectivity over other closely related kinases. (C) 2008 Published by Elsevier Ltd.

  DOI：

  10.1016/j.bmcl.2007.10.023

文献信息

• Inhibitors of Akt Activity
  申请人：Bilodeau T. Mark

  公开号：US20070254901A1

  公开（公告）日：2007-11-01

  The present invention is directed to compounds which contain substituted 5-deazapteridine moieties which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

  本发明涉及含有取代的5-脱氨嘌呤基团的化合物，该化合物抑制Akt蛋白激酶的活性。该发明还涉及含有本发明化合物的化疗组合物以及治疗癌症的方法，包括给予本发明化合物的治疗方法。
• Inhibitors of akt activity
  申请人：Bilodeau T Mark

  公开号：US20070043001A1

  公开（公告）日：2007-02-22

  The present invention is directed to compounds which contain a substituted pyridine moeity which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.

  本发明涉及化合物，其中包含取代的吡啶基团，可抑制Akt蛋白激酶的活性。本发明还涉及含有本发明化合物的化疗组合物和治疗癌症的方法，包括给予本发明化合物的治疗方法。
• [EN] INHIBITORS OF AKT ACTIVITY<br/>[FR] INHIBITEURS DE L'ACTIVITE DE AKT
  申请人：MERCK & CO INC

  公开号：WO2006036395A3

  公开（公告）日：2007-12-21
• INHIBITORS OF AKT ACTIVITY
  申请人：Merck Sharp & Dohme Corp.

  公开号：EP1622616B1

  公开（公告）日：2011-06-15
• US7223738B2
  申请人：——

  公开号：US7223738B2

  公开（公告）日：2007-05-29